Status:
UNKNOWN
Light Emitting Diode in the Treatment of Genitourinary Syndrome of Menopause
Lead Sponsor:
Patricia Lordelo
Collaborating Sponsors:
University of Messina
Conditions:
Atrophy;Vaginal
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Introduction: The genitourinary menopause syndrome (MMS) affects 50% of postmenopausal women and, due to a decrease in hormone levels, triggers functional changes in the vagina and vagina, and impairm...
Eligibility Criteria
Inclusion
- menopausal women up to 65 years of age
- presence of clinical signs and symptoms of Menopause Genitourinary Syndrome :dryness and irritation of the vagina, pruritus, pain or discomfort in sexual intercourse, bleeding after sexual intercourse
- voluntarily participate in the research.
Exclusion
- patients undergoing hormone replacement for less than 6 months
- diagnosis of vaginal infection
- difficulty in understanding the proposed instruments
- patients with chronic neurological degenerative diseases.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04902794
Start Date
December 1 2021
End Date
December 1 2023
Last Update
June 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Patrícia Lordelo
Salvador, Estado de Bahia, Brazil, 41825-000